Cell Growth & Differentiation, Vol 6, Issue 9 1045-1052, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors

E Liaudet, D Derocq, H Rochefort and M Garcia
Institut National de la Sante et de la Recherche Medicale, Unite Hormones et Cancer, U 148, Montpellier, France.

Cathepsin D, a lysosomal protease, is overexpressed in primary breast cancer and associated with increased risk of metastasis. We have shown previously by transfection in rat tumor cells that overexpression of cathepsin D increased both experimental metastasis in nude mice and in vitro proliferation under low-serum conditions. In this study, we used the transfected cell lines to investigate the mechanism by which cathepsin D prevents density-dependent arrest of cell proliferation. This effect was not associated with a general alteration of cell-substratum or cell-cell adhesiveness. As shown by coculture and conditioned media experiments, control cells reaching saturation density released inhibitory activity that was able to prevent the growth of control or cathepsin D transfectants and decreased the cloning efficiency of normal rat kidney fibroblasts in agar. By contrast, in media from two cathepsin D-transfected cell lines, this inhibitory activity was markedly reduced. Cathepsin D overexpression did not affect cell sensitivity to the inhibitor but modified the secretion of several proteins. The increase in cell density appeared to be due to intracellular maturation of cathepsin D since it was reversed by amine treatment that neutralizes the pH of acidic compartments within the cells. Moreover, the addition of secreted pro-cathepsin D was unable to increase the saturation density of control clones. Finally, the inhibitory factor was partially characterized as a heat-labile, secreted protein. We conclude that cathepsin D overexpression increases the growth of cancer cells to a higher density via an intracellular mechanism, leading to a decreased secretion of growth inhibitor(s).

This article has been cited by other articles:

				Y. Choi, R. Weissleder, and C.-H. Tung Selective antitumor effect of novel protease-mediated photodynamic agent. Cancer Res., July 15, 2006; 66(14): 7225 - 7229. [Abstract] [Full Text] [PDF]

				M. E. Fukuda, Y. Iwadate, T. Machida, T. Hiwasa, Y. Nimura, Y. Nagai, M. Takiguchi, H. Tanzawa, A. Yamaura, and N. Seki Cathepsin D Is a Potential Serum Marker for Poor Prognosis in Glioma Patients Cancer Res., June 15, 2005; 65(12): 5190 - 5194. [Abstract] [Full Text] [PDF]

				V. Laurent-Matha, S. Maruani-Herrmann, C. Prebois, M. Beaujouin, M. Glondu, A. Noel, M. L. Alvarez-Gonzalez, S. Blacher, P. Coopman, S. Baghdiguian, et al. Catalytically inactive human cathepsin D triggers fibroblast invasive growth J. Cell Biol., January 31, 2005; 168(3): 489 - 499. [Abstract] [Full Text] [PDF]

				Z.-H. Qin, Y. Wang, K. B. Kegel, A. Kazantsev, B. L. Apostol, L. M. Thompson, J. Yoder, N. Aronin, and M. DiFiglia Autophagy regulates the processing of amino terminal huntingtin fragments Hum. Mol. Genet., December 15, 2003; 12(24): 3231 - 3244. [Abstract] [Full Text] [PDF]

				U. Mahmood and R. Weissleder Near-Infrared Optical Imaging of Proteases in Cancer Mol. Cancer Ther., May 1, 2003; 2(5): 489 - 496. [Abstract] [Full Text] [PDF]

				C.-H. Tung, U. Mahmood, S. Bredow, and R. Weissleder In Vivo Imaging of Proteolytic Enzyme Activity Using a Novel Molecular Reporter Cancer Res., September 1, 2000; 60(17): 4953 - 4958. [Abstract] [Full Text]

				A Journet, A Chapel, S Jehan, C Adessi, H Freeze, G Klein, and J Garin Characterization of Dictyostelium discoideum cathepsin D J. Cell Sci., January 11, 1999; 112(21): 3833 - 3843. [Abstract] [PDF]

				M Garcia, N Platet, E Liaudet, V Laurent, D Derocq, J. Brouillet, and H Rochefort Biological and clinical significance of cathepsin D in breast cancer metastasis Stem Cells, November 1, 1996; 14(6): 642 - 650. [Abstract]